JPMorgan lowered the firm’s price target on Keurig Dr Pepper (KDP) to $38 from $39 and keeps an Overweight rating on the shares ahead of the Q2 report on July 24. The firm trimmed estimates on softer U.S. refreshment beverages and international volume. It believes Keurig Dr Pepper remains well positioned for fiscal 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Keurig Dr Pepper Positioned for Growth with Strong Cold Beverage Performance and Attractive Valuation
- 3 Must-Watch Stocks with a ‘Perfect 10’ Smart Score
- Keurig Dr Pepper price target lowered to $37 from $38 at Barclays
- Keurig Dr Pepper reaffirms view of high-single-digit FY25 adjusted EPS growth
- Keurig Dr Pepper Reaffirms 2025 Financial Guidance